Loading clinical trials...
Loading clinical trials...
A Phase III Randomized Trial Comparing TAH BSO Versus TAH BSO Plus Adjuvant Pelvic Irradiation in Intermediate Risk Carcinoma of the Endometrium
Conditions
Interventions
radiation therapy
Locations
25
United States
St. Mary's - Duluth Clinic Cancer Center
Duluth, Minnesota, United States
Royal Women's Hospital
Carlton, Victoria, Australia
Tom Baker Cancer Centre - Calgary
Calgary, Alberta, Canada
Cross Cancer Institute
Edmonton, Alberta, Canada
Fraser Valley Cancer Centre at British Columbia Cancer Agency
Surrey, British Columbia, Canada
British Columbia Cancer Agency - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
Start Date
July 4, 1996
Primary Completion Date
December 1, 2007
Completion Date
December 21, 2009
Last Updated
April 6, 2020
NCT05489211
NCT04657068
NCT04585750
NCT07029399
NCT06975293
NCT07166094
Lead Sponsor
NCIC Clinical Trials Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions